Dutch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Deutsche Medizinische Wochenschrift 2007-Mar

[Early warning system for pulmonary fluid status monitoring in terminal heart failure].

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
De link wordt op het klembord opgeslagen
H Wedekind
K Möller

Sleutelwoorden

Abstract

METHODS

A 38-year-old man was admitted for increasing dyspnea, nausea and emesis during the preceding year. Clinically he was in heart failure NYHA stage III. He had not been on any regular medication and had no other medical complaints. Physical examination revealed a pulse of 100/min., hypotension (100/60 mmHg) and jugular vein distension. Bilateral pulmonary rales were noted on auscultation. A slight edema of both lower legs was noted.

METHODS

A 12-lead electrocardiogram showed complete left bundle branch block with a QRS duration of 160 ms. Chest x-ray revealed cardiomegaly with pulmonary vascular congestion. Transthoracic echocardiography demonstrated reduced left ventricular function with an ejection fraction of 10-15%. Left heart catheterization excluded coronary heart disease and confirmed the decreased left ventricular function.

METHODS

Medical treatment for heart failure secondary to dilated cardiomyopathy was initiated without significant improvement in clinical status. Cardiac resynchronization therapy (CRT) was therefore performed with implantation of a biventricular pacer with defibrillator (CRT-D) and a fluid status monitoring system (OptiVol). Subsequently the patient was able to increase his physical activity to NYHA class II and was followed in our outpatient clinic. Since initial treatment the patient has been seen twice for clinical signs of pulmonary edema. Both times the fluid monitoring system of the CRT-D gave an alarm signal early enough to allow cardiac re-compensation by expanding the current medication. Both times hospital admission was avoided.

CONCLUSIONS

Cardiac resynchronization therapy has been established as an adjunct to optimal pharmacological therapy in eligible patients with severe heart failure. A fluid status monitoring system integrated into the device measures intrathoracic impedance, allowing patients to be alerted before the onset of symptoms of fluid overload. Thus, treatment can be adjusted and hospitalization is avoidable.

Word lid van onze
facebookpagina

De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap

  • Werkt in 55 talen
  • Kruidengeneesmiddelen gesteund door de wetenschap
  • Kruidenherkenning door beeld
  • Interactieve GPS-kaart - tag kruiden op locatie (binnenkort beschikbaar)
  • Lees wetenschappelijke publicaties met betrekking tot uw zoekopdracht
  • Zoek medicinale kruiden op hun effecten
  • Organiseer uw interesses en blijf op de hoogte van nieuwsonderzoek, klinische onderzoeken en patenten

Typ een symptoom of een ziekte en lees over kruiden die kunnen helpen, typ een kruid en zie ziekten en symptomen waartegen het wordt gebruikt.
* Alle informatie is gebaseerd op gepubliceerd wetenschappelijk onderzoek

Google Play badgeApp Store badge